NOTICE!
Due to lack of funding and of volunteers, NCHC waas forced to close it's doors
at the end of September 2005. We enjoyed a long and fruitful 10 years, but
with the economic system the way it is, there was no way that we can continue
as we have in the past. It has become too much to ask for the volunteers to carry
the financial load any longer. This site will remain, but it will no longer be
aggressively maintained and all links have been removed by necessity. All services will be
discontinued as well, with exceptions. You may still reach us by snail mail:
NCHC2000, PO box 27435,
Fresno, California, USA, 93729-7435. Thank you for all of your
attention in the past. God speed and blessings to all. The Staff and Director
of NCHC
ALL NCHC Certification papers will expire at the end of 2008. Persons holding
certification through NCHC must reapply by snail mail prior to that date. Our address
is shown in blue above. This is
the only service that will continue through NCHC.
Tracey's Health
Tips by
Tracey Behn*, Staff
Editor/Researcher
Antineoplaston Therapy
Antineoplaston therapy was discovered by Dr. Stanislaw R. Burzynski,
who practices in Houston, Texas, and is
being used by him to treat cancer, HIV infection, and autoimmune diseases.
For over 20 years, Dr. Burzynski has been attacking cancer in humans, in
over 3,000 patients. Antineoplaston therapy is unlike the chemotherapy
agents currently in use that kill cancerous cells and healthy cells.
Antineoplastons work on cancer cells to interrupt the activity of the ras
oncogene, which causes cells to divide endlessly. At the same time,
antineoplastons stimulate p53 tumor suppressor genes, which tell the cells
to undergo programmed cell death. Healthy cells remain unaffected under
these processes.
Dr. Burzynski first discovered and named antineoplastons in the late 1960s.
These drugs are safe and nontoxic, unlike traditional chemotherapeutic agents.
Antineoplastons are comprised of compounds that occur naturally in the
human body: amino acid derivatives and peptides from proteins and essential
amino acids present in the diet of all biologic organisms. Antineoplastons are
found in the blood of healthy persons and not in that of patients with cancer.
Dr. Burzynski currently is using antineoplastons to treat cancer, HIV infection,
and autoimmune diseases in 74 Phase II clinical trials.
The chemotherapeutic agents in common use today cannot manage cancer
for two reasons. First, they destroy healthy cells; therefore, these drugs cannot
be taken over long periods of time, as can antineoplastons. Second, no one
chemotherapeutic drug can kill all the cancer cells. Just as there are antibiotic-
resistant strains of bacteria, cancer cell types exist that are resistant to specific
chemotherapeutic agents.
When a chemotherapeutic agent leaves 10% of cancer cells remaining, there
may be billions of cells that survive, say, 10 billion. A different
chemotherapeutic agent may kill 90% of those cells, leaving behind one
billion cells. Still another agent may destroy 90% of those cells, leaving
100 million cells. Of course, all the while, these cells are multiplying.
Because they reprogram cancer cells instead of killing them, antineoplastons
do not stop working as do traditional chemotherapy agents. Therefore,
antineoplastons are making cancer a manageable disease.
NCHC Note: Search the web on the topic of "Antineoplaston Therapy" for additional information
and be sure to discuss this information with your physician.
Author Unknown - © 2003 in Escrow by NCHC
*Tracey lives in northeastern West Virginia, where she
works as a Senior Computer Systems Operator for a large organization.
At home, in her "free" time, she scans the web for her tips and
paraphrases much of what she finds for us. You can reach her by email
at:
tbehn @a nchc 2000.org
Check out
Tracey's
Tips
Page here
for more useful health
tips!
|
2001
